Occutrack Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Series A
- Investors
-
4
Occutrack General Information
Description
Developer of vision tracking system designed to manage central vision deterioration. The company utilizes the Automatic Visual Impairment Detection System which is an advanced gaze-tracking algorithm that provides consistent and comfortable non-invasive vision monitoring to prevent further deterioration of central vision loss, enabling customers with a comprehensive and intelligent assessment of visual performance and improve quality of life.
Contact Information
Website
www.occutrack.com.sgCorporate Office
- 77 Ayer Rajah Crescent
- Suite 02-21/26
- Singapore, 139954
- Singapore
Corporate Office
- 77 Ayer Rajah Crescent
- Suite 02-21/26
- Singapore, 139954
- Singapore
Occutrack Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series A) | 15-Feb-2024 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 2. Seed Round | 08-Apr-2022 | $339K | $339K | Completed | Generating Revenue | |
| 1. Seed Round | 01-Aug-2020 | Completed | Startup |
Occutrack Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Occutrack Patents
Occutrack Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4225125-A1 | Method and system for conducting a vision assessment test using authored test profiles | Pending | 27-Oct-2020 | ||
| EP-4225125-A4 | Method and system for conducting a vision assessment test using authored test profiles | Pending | 27-Oct-2020 | ||
| US-20230389790-A1 | Method and system for conducting a vision assessment test using authored test profiles | Pending | 27-Oct-2020 | ||
| WO-2022093105-A1 | Method and system for conducting a vision assessment test using authored test profiles | Inactive | 27-Oct-2020 | A61B3/024 |
Occutrack Signals
Occutrack Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Accelerate Technologies | Corporation | Minority | ||
| National Healthcare | Corporation | Minority | ||
| Trendlines | Corporation | Minority | ||
| Collab Novena | Accelerator/Incubator |
Occutrack FAQs
-
When was Occutrack founded?
Occutrack was founded in 2019.
-
Where is Occutrack headquartered?
Occutrack is headquartered in Singapore, Singapore.
-
What is the size of Occutrack?
Occutrack has 3 total employees.
-
What industry is Occutrack in?
Occutrack’s primary industry is Diagnostic Equipment.
-
Is Occutrack a private or public company?
Occutrack is a Private company.
-
What is Occutrack’s current revenue?
The current revenue for Occutrack is .
-
How much funding has Occutrack raised over time?
Occutrack has raised $339K.
-
Who are Occutrack’s investors?
Accelerate Technologies, National Healthcare, Trendlines, and Collab Novena have invested in Occutrack.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process